The next ISEH webinar is scheduled for Tuesday, 25 October at 1:30 pm EDT - 3:00 pm EDT.
Utility of CRISPR/Cas9 systems in hematology research
The discovery of the CRISPR/Cas9 system has led to a revolution in genome editing technology. The ease of gene targeting and manipulation with this approach and its derivatives have unlocked a plethora of previously unimaginable experimental areas within all disciplines of biomedical research. In this webinar, we will hear from experts in the field about the most cutting-edge applications of CRISPR/Cas9 targeting in the study of normal and malignant hematopoiesis, and how these approaches might one day benefit a wide range of patients with blood disorders.
Chad Cowan, Harvard Stem Cell Institute
Ben Ebert, Brigham and Women's Hospital
Eirini Papapetrou, Icahn School of Medicine at Mount Sinai